Rs10494366
From SNPedia
| is a | snp |
| is | mentioned by |
| dbSNP | rs10494366 |
| hapmap | rs10494366 |
| hgdp | rs10494366 |
| ensembl | rs10494366 |
| gopubmed | rs10494366 |
| scholar | rs10494366 |
| rs10494366 | |
| pharmgkb | rs10494366 |
| hgvbaseg2p | rs10494366 |
| medrefsnp | rs10494366 |
| 23andMe | rs10494366 |
| SNP Nexus |
| Gene | NOS1AP |
| Chromosome | 1 |
| Orientation | plus |
| Position | 160352308 |
| Genotype | Effect |
|---|---|
| rs10494366(G;G) | Long QT interval |
| rs10494366(G;T) | average QT interval |
| rs10494366(T;T) | Shorter QT interval |
| Genotypes | Magnitude | Summary |
|---|---|---|
| Rs10494366(G;G) | Long QT interval | |
| Rs10494366(G;T) | 00 | average QT interval |
| Rs10494366(T;T) | 22 | Shorter QT interval |
A follow-up study determined that one rs10494366(G) allele was associated with a 3.8-ms (CI: 3.0 - 4.6ms, p=7.8x10(-20)) increase in QT interval duration, and two (G) alleles had twice that increase. No increase in risk for sudden death due to a cardiac problem was associated with this SNP, though. [PMID 17576865]
[PMID 18235038] rs10494366 minor homozygotes had a 9.3 msec longer QT interval compared to major homozygotes (p=5.7x10(-5)); rs10918594 minor homozygotes had a 12.5 msec longer QT interval compared to major homozygotes (p=1.5x10(-6)). Restricting analyses to the diabetic EAs strengthened the effect despite the reduction in sample size (11.3 msec difference, p=5.1x10(-5); 13.9 msec difference, p=1.6x10(-6), respectively).
[PMID 18551039] Patients with rs10494366(G;T) or (G;G) genotypes have an increased mortality risk (hazard ratio 2.8) compared to (T;T) genotypes upon treatment with sulfonylurea antidiabetic drugs. Glibenclamide is less effective in reducing glucose levels and mortality rates were higher compared with glibenclamide users with the (T;T) genotype. However, in tolbutamide and glimepiride users, the (G;T) and (G;G) genotypes were associated with a reduced mortality rate.
[PMID 19204306] rs10494366, rs4657139 and rs16847548 were significantly associated with adjusted QT interval in whites. relative hazard of SCD associated with each C allele at rs16847548 was 1.31. rs12567209 was also independently associated with SCD in whites (relative hazard 0.57, 95% confidence interval 0.39 to 0.83, P=0.003). No significant associations observed in blacks.
| ? | (G;G) (G;T) (T;T) |
|---|---|
|
| |
| GWAS | |
|---|---|
| SNP | rs10494366 |
| PubMedID | [PMID 16648850] |
| Condition | QT interval prolongation |
| Gene | NOS1AP |
| Risk Allele | |
| pValue | 1.00E-010 |
| OR | 4.9 |
| 95% CI | 7.90 (NR) msec difference between homozygote |
[PMID 19247217] Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation
[PMID 19943157] NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study
| PharmGKB | PA161748484 |
| Name | |
| Annotation | This variant in intron 1 of the NOS1AP gene has been associated with resting QTc in a genome-wide association scan and replicated in independent populations. |
| Gene | NOS1AP |
| Featue | |
| Evidence | PubMed ID:16648850; PubMed ID:17565224; PubMed ID:17576865; PubMed ID:18511491 |
| Drugs | |
| Diseases | |
| Curation Level | Curated |
[PMID 19289301] SNP association and sequence analysis of the NOS1AP gene in SIDS
| GWAS snp | |
|---|---|
| PMID | [PMID 20062063] |
| Trait | Electrocardiographic traits |
| Title | Several common variants modulate heart rate, PR interval and QRS duration |
| Risk Allele | G |
| P-val | 5E-22 |
| Odds Ratio | 12.20 [9.72-14.68] % SD increase |
[PMID 20215044] Relationship of Common Candidate Gene Variants to Electrocardiographic T-Wave Peak to T-Wave End Interval and T-Wave Morphology Parameters